Solventum Corp | SOLV - Selling And Administration Expenses


Solventum Corp reported $759M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Abbott USD 3.13B 125M Dec/2025
Align Technology USD 441.68M 23.88M Dec/2025
Baxter International USD 761M 53M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Cencora USD 1.8B 46.42M Dec/2025
Dexcom USD 299.9M 31.5M Dec/2025
Insulet USD 331.4M 16.2M Dec/2025
Solventum Corp USD 759M 15M Dec/2025
West Pharmaceutical Services USD 106.5M 3.8M Dec/2025
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025